PriceTargets.com logo

Modular Medical - MODD Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $4.25
  • Forecasted Upside: 245.53%
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$1.23 As of 09/28/2023 03:39 PM ET
▲ +0.07 (6.03%)

This chart shows the closing price for MODD by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Modular Medical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MODD and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MODD

Analyst Price Target is $4.25
▲ +245.53% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Modular Medical in the last 3 months. The average price target is $4.25, with a high forecast of $5.00 and a low forecast of $3.50. The average price target represents a 245.53% upside from the last price of $1.23.

This chart shows the closing price for MODD for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 2 polled investment analysts is to buy stock in Modular Medical. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/5/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/4/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/2/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/31/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/31/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/29/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/28/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/27/2023

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/19/2023OppenheimerReiterated RatingOutperform ➝ Outperform$3.50Low
6/30/2023BenchmarkReiterated RatingSpeculative Buy ➝ Speculative Buy$5.00N/A
5/19/2023OppenheimerLower Target$6.00 ➝ $3.50N/A
1/30/2023BenchmarkLower TargetSpeculative Buy$8.00 ➝ $5.00N/A
4/8/2022Lake Street CapitalInitiated CoverageBuy$11.00N/A
3/25/2022BenchmarkInitiated CoverageBuy$8.00N/A
(Data available from 9/28/2018 forward)

News Sentiment Rating

0.16 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/2/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/1/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/1/2023
  • 2 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
5/31/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/30/2023
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/30/2023
  • 1 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/29/2023
  • 1 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/28/2023

Current Sentiment

  • 1 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Modular Medical logo
Modular Medical, Inc. operates as a development stage medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for diabetes. The company was founded in 1998 and is headquartered in San Diego, California.
Read More

Today's Range

Now: $1.23
Low: $1.11
High: $1.24

50 Day Range

MA: $1.09
Low: $0.86
High: $1.32

52 Week Range

Now: $1.23
Low: $0.84
High: $4.50

Volume

3,406 shs

Average Volume

148,742 shs

Market Capitalization

$25.94 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.11

Frequently Asked Questions

What sell-side analysts currently cover shares of Modular Medical?

The following equities research analysts have issued research reports on Modular Medical in the last twelve months: Benchmark Co., and Oppenheimer Holdings Inc..
View the latest analyst ratings for MODD.

What is the current price target for Modular Medical?

2 Wall Street analysts have set twelve-month price targets for Modular Medical in the last year. Their average twelve-month price target is $4.25, suggesting a possible upside of 245.5%. Benchmark Co. has the highest price target set, predicting MODD will reach $5.00 in the next twelve months. Oppenheimer Holdings Inc. has the lowest price target set, forecasting a price of $3.50 for Modular Medical in the next year.
View the latest price targets for MODD.

What is the current consensus analyst rating for Modular Medical?

Modular Medical currently has 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe MODD will outperform the market and that investors should add to their positions of Modular Medical.
View the latest ratings for MODD.

What other companies compete with Modular Medical?

Other companies that are similar to Modular Medical include PetVivo, Femasys, Spectral AI, NeuroOne Medical Technologies and STRATA Skin Sciences. Learn More about companies similar to Modular Medical.

How do I contact Modular Medical's investor relations team?

Modular Medical's physical mailing address is 10740 Thornmint Road, San Diego, CA 92127, United States. The company's listed phone number is (858) 800-3500 and its investor relations email address is [email protected]. The official website for Modular Medical is modular-medical.com. Learn More about contacing Modular Medical investor relations.